New ProductsView all New Products Alphabetically
Search for new products by date added, alphabetically, or by pharmacological action.
New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules and peptides being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can. New products can be identified throughout the Tocris website by the New symbol.
If you can't find what you are looking for we welcome new product suggestions. If you would like to be kept informed about new products by email, please sign up for our monthly e-alert service.
| Cat. No. | Product Name / Activity | Date Added |
|---|---|---|
| 7220 | A 410099.1 amide-PEG4-amine | Jun 2020 |
| A 410099.1 amide-PEG4-amine | ||
| 7221 | A 410099.1 amide-PEG5-amine | Jun 2020 |
| A 410099.1 amide-PEG5-amine | ||
| 6130 | AP 1903 | Jul 2020 |
| Protein dimerizer; active in vivo | ||
| 7001 | AT 7867 | Jun 2020 |
| Potent pan-Akt and PKA inhibitor | ||
| 6826 | AZ 1729 | Mar 2020 |
| FFA2 allosteric agonist; displays bias for the Gi signaling pathway | ||
| 7121 | 7-Aminoactinomycin D | Feb 2020 |
| Fluorescent DNA stain | ||
| 7235 | Arbidol | Jul 2020 |
| Broad spectrum antiviral | ||
| 6791 | BC-LI-0186 | Feb 2020 |
| Leucyl-tRNA synthase (TRS)/Ras-related GTP-binding protein D (RagD) interaction inhibitor | ||
| 7222 | Baricitinib | Jun 2020 |
| Highly potent JAK1 and JAK2 inhibitor; also inhibits JAK3 and Tyk2 | ||
| 7040 | C 176 | Feb 2020 |
| mSTING antagonist | ||
| 6391 | CD38 inhibitor 78c | Jun 2020 |
| Potent CD38 inhibitor; active in vivo | ||
| 6758 | CLP 290 | Mar 2020 |
| K+/Cl- cotransporter 2 (KCC2) activator; orally bioavailable prodrug of CLP 257 (Cat. No.5242) | ||
| 6354 | CNV Dopamine | May 2020 |
| Caged dopamine; photolysed by UV light | ||
| 7116 | Chemerin-9, Human | Apr 2020 |
| Potent CMKLR1 agonist; c-terminal peptide of full length human chemerin | ||
| 7117 | Chemerin-9, Mouse | Apr 2020 |
| Potent CMKLR1 agonist; c-terminal peptide of full length mouse chemerin | ||
| 7163 | Chroman 1 | Mar 2020 |
| Highly potent and selective ROCK 2 inhibitor; improves cell survival after cryogeneisis | ||
| 7056 | Conduritol B epoxide | Jun 2020 |
| Irreversible glucocerebrosidase (β-glucosidase) inhibitor; used to generate Gaucher disease models | ||
| 6457 | Cyanine 3 Tyramide | Jan 2020 |
| Orange fluorescent reagent widely used for signal amplification in IHC and ISH | ||
| 6458 | Cyanine 5 Tyramide | Jan 2020 |
| Red fluorescent reagent widely used for signal amplification in IHC and ISH | ||
| 6873 | DC 271 | Jul 2020 |
| Fluorescent retinoic acid analog; solvochromatic probe | ||
| 7082 | DL 175 | Apr 2020 |
| Potent and selective GPR84 agonist | ||
| 7223 | Dabrafenib mesylate | Jun 2020 |
| Potent and selective B-Raf, CDK16 and NEK9 inhibitor; anticancer; also targets human proteins in the SARS-CoV-2 interactome | ||
| 6779 | Davunetide | Apr 2020 |
| Highly potent active component of ADNP; prevents amyloid β aggregation; active in vivo | ||
| 7090 | Digoxigenin-11-dUTP | Mar 2020 |
| Hapten modified dUTP for ISH | ||
| 6896 | Dynapyrazole A | May 2020 |
| Hedgehog signaling inhibitor; dynein inhibitor | ||
| 7225 | Favipiravir | Jun 2020 |
| Viral RNA polymerase inhibitor | ||
| 6456 | Fluorescein Tyramide | Jan 2020 |
| Green fluorescent reagent widely used for signal amplification in IHC and ISH | ||
| 7227 | GS 441524 | Jun 2020 |
| Viral RNA-dependent RNA polymerase inhibitor; broad spectrum antiviral nucelotide | ||
| 5814 | GoSlo SR 5-69 | Apr 2020 |
| BK channel activator | ||
| 6110 | HJC 0416 hydrochloride | Feb 2020 |
| STAT3 inhibitor | ||
| 7015 | IA-Alkyne | Jan 2020 |
| Broad spectrum cysteine reactive probe | ||
| 6962 | JBJ-03-142-02 | May 2020 |
| Highly potent EGFR and ErbB2 inhibitor; inhibts wild type and mutated receptors | ||
| 6976 | JNJ 10198409 | Mar 2020 |
| Potent PDGFRα and PDGFRβ inhbitor; also inhibits c-Abl, Lck, c-Src and Fyn kinases | ||
| 7088 | Janelia Fluor® 646, Azide | Feb 2020 |
| Red dye (Reactive group: azide). Applications: super resolution microscopy e.g. dSTORM & STED, confocal, and live cell imaging | ||
| 6993 | Janelia Fluor® 646, free acid | Feb 2020 |
| Red dye (Reactive group: free acid). Applications: super resolution microscopy e.g. dSTORM & STED, confocal, flow and live cell imaging | ||
| 6964 | LY 2119620 | Jan 2020 |
| Positive allosteric modulator of M2 and M4 receptors | ||
| 7081 | LY 2886721 Hydrochloride | Jun 2020 |
| Potent and selective β-secretase (BACE) inhibitor | ||
| 7052 | Lopinavir | Jun 2020 |
| Highly potent and selective HIV-1 protease inhibitor | ||
| 6858 | MMG 11 | Jan 2020 |
| TLR2 antagonist | ||
| 7004 | NAI | May 2020 |
| Reagent for RNA SHAPE-MaP experiments in vivo; cell permeable | ||
| 6722 | NBC 19 | Apr 2020 |
| Potent NLRP3 inflammasome inhibitor | ||
| 6925 | NBC 6 | Jan 2020 |
| NLRP3 inflammasome inhibitor | ||
| 5746 | NESS 0327 | Feb 2020 |
| Ultra-high affinity and selective CB1 antagonist | ||
| 6807 | NNC 0640 | May 2020 |
| Negative allosteric modulator of glucagon and GLP-1 receptors | ||
| 7177 | NR 7h | May 2020 |
| Potent and selective p38α and p38β degrader; active in vivo | ||
| 7234 | Nitazoxanide | Jul 2020 |
| Pyruvate flavodoxin/ferredoxin oxidoreductase inhibitor; also inhibits Wnt signaling; broad spectrum anti-infective | ||
| 7246 | Nucleic Acid Dye Green I | Jun 2020 |
| High affinity double-stranded DNA (dsDNA) probe; used in RT-LAMP and qPCR | ||
| 7224 | Oseltamivir phosphate | Jul 2020 |
| Influenza virus neuraminidase inhibitor; antiviral prodrug | ||
| 5755 | PF 04479745 | Apr 2020 |
| Potent and selective 5-HT2C agonist | ||
| 6220 | PM 226 | Jan 2020 |
| Potent and selective CB2 receptor agonist; BBB permeable; neuroprotective | ||
| 6372 | PSB CB5 | Mar 2020 |
| Selective GPR18 antagonist | ||
| 7038 | Palonosetron hydrochloride | Feb 2020 |
| Highly potent and high affinity 5-HT3 antagonist | ||
| 7203 | Pomalidomide 4'-PEG1-amine | Jul 2020 |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | ||
| 7204 | Pomalidomide 4'-PEG3-amine | Jul 2020 |
| Cereblon ligand with PEG linker and terminal amine for onward chemistry | ||
| 7096 | Pomalidomide 4'-alkylC3-acid | Jul 2020 |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | ||
| 7205 | Pomalidomide 4'-alkylC3-amine | Jun 2020 |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | ||
| 7210 | Pomalidomide 4'-alkylC6-acid | Jul 2020 |
| Cereblon ligand with alkyl linker and terminal acid for onward chemistry | ||
| 7208 | Pomalidomide 4'-alkylC7-amine | Jul 2020 |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | ||
| 6944 | Pomalidomide 4'-alkylC8-amine | Apr 2020 |
| Cereblon ligand with alkyl linker and terminal amine for onward chemistry | ||
| 6649 | RADA | Apr 2020 |
| Orange-red TAMRA-based fluorescent D-amino acid for labeling peptidoglycans in live bacteria | ||
| 6892 | RIPGBM | Apr 2020 |
| RIPK2 modulator; pro-drug of cRIPGM; orally bioavailable and brain penetrant | ||
| 6833 | RO 5263397 hydrochloride | Feb 2020 |
| Potent TA1 receptor agonist | ||
| 7226 | Remdesivir | Jun 2020 |
| Viral RNA-dependent RNA polymerase inhibitor; broad spectrum antiviral nucelotide prodrug | ||
| 7064 | Ruxolitinib | Feb 2020 |
| Potent and selective JAK1/JAK2 inhibitor; orally bioavailable | ||
| 7048 | Ruxolitinib phosphate | Feb 2020 |
| Phosphate salt of Ruxolitinib (Cat. No. 7064); potent and selective JAK1/JAK2 inhibitor | ||
| 7233 | SBP1 | May 2020 |
| ACE2 derived peptide; binds SARS-CoV-2 spike protein receptor binding domain | ||
| 7232 | SBP1-FITC | Jun 2020 |
| Fluorescent ACE2-derived peptide; binds receptor binding domain of SARS-CoV-2 spike protein | ||
| 6825 | SGC 3027 | May 2020 |
| Potent and selective PRMT7 inhibitor | ||
| 6838 | SGC 3027N | May 2020 |
| Negative control for SGC 3027 (Cat. No. 6825) | ||
| 6998 | SHIN 1 | May 2020 |
| Potent SHMT inhibitor | ||
| 7039 | SK 609 | Feb 2020 |
| Dopamine D3 receptor biased agonist | ||
| 6398 | SKA 121 | Jan 2020 |
| Positive allosteric modulator of KCa3.1 channels | ||
| 6670 | TP 238 | Mar 2020 |
| CECR2 and BPTF/FALZ inhibitor | ||
| 6831 | TRPV3 74a | May 2020 |
| Selective TRPV3 antagonist; brain penetrant | ||
| 6430 | Takinib | Jun 2020 |
| Potent and selective TAK1/MAP3K7 kinase inhibitor | ||
| 7051 | Tasquinimod | Jan 2020 |
| High affinity HDAC4 negative allosteric modulator; also binds S100A9; antiangiogenic | ||
| 7150 | Tocriscreen 2.0 Max | Jan 2020 |
| A library of 1280 biologically active compounds (250 μL 10 mM DMSO solutions) | ||
| 7152 | Tocriscreen 2.0 Micro | Jan 2020 |
| A library of 1280 biologically active compounds (15 μL 10 mM DMSO solutions) | ||
| 7151 | Tocriscreen 2.0 Mini | Jan 2020 |
| A library of 1280 biologically active compounds (50 μL 10 mM DMSO solutions) | ||
| 7200 | Tocriscreen FDA-Approved Drugs Library | Apr 2020 |
| Drug repurposing library; a library of 190 compounds equivalent to active components of drug formulations approved by the FDA | ||
| 6985 | VH 032 amide-alkylC5-amine | Jan 2020 |
| VHL ligand with alkyl linker and terminal amine for onward chemistry | ||
| 7074 | VH 032 amide-alkylC7-amine | Mar 2020 |
| VHL ligand with alkyl linker and terminal amine for onward chemistry | ||
| 6911 | VH 032, phenol | Mar 2020 |
| Hydroxyl functionalized VHL ligand | ||
| 6952 | VH 101, phenol | Jan 2020 |
| Hydroxyl functionalized VHL ligand | ||
| 6928 | VU 6001966 | Feb 2020 |
| Potent and selective negative allosteric modulator of mGlu2 receptors | ||
| TB3748-GMP | XAV 939 | Jan 2020 |
| XAV 939 synthesized to cGMP guidelines | ||
| 6650 | YADA | May 2020 |
| Green-yellow lucifer yellow-based fluorescent D-amino acid for labeling peptidoglycans in live bacteria | ||
| 6739 | YNT 185 | Mar 2020 |
| Potent and selective OX2 agonist | ||
| 6599 | Yhhu 3792 | Jun 2020 |
| Notch signaling pathway activator; enhances the self-renewal capability of NSCs; active in vivo | ||
| 6939 | cis-VZ 185 | Mar 2020 |
| Negative control for VZ 185 (Cat. No. 6936) | ||
| 6945 | dBET6 | Jun 2020 |
| Potent and selective (+)-JQ1 based PROTAC targeting BET bromodomains, active in vivo | ||
| 6943 | dBRD9-A | Jul 2020 |
| Potent BRD9 Degrader | ||
| 7162 | iFSP1 | Feb 2020 |
| Ferroptosis suppressor protein 1 (FSP1) inhibitor; ferroptosis inducer |